masoprocol has been researched along with Cancer of Nose in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aozasa, K; Chng, WJ; Feldman, AL; Huang, G; Kagami, Y; Kwong, YL; Law, M; Ng, SB; Salto-Tellez, M; Selvarajan, V; Shimizu, N; Zhou, J | 1 |
1 other study(ies) available for masoprocol and Cancer of Nose
Article | Year |
---|---|
Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apoptosis; Female; Gene Expression Profiling; Gene Regulatory Networks; Genome-Wide Association Study; Humans; Inhibitor of Apoptosis Proteins; Killer Cells, Natural; Lymphoma, Extranodal NK-T-Cell; Male; Masoprocol; Microtubule-Associated Proteins; Middle Aged; Neoplasm Proteins; NF-kappa B; Nose Neoplasms; Oncogenes; Proto-Oncogene Proteins c-myc; Survivin; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Young Adult | 2011 |